Summary: This paper describes a fully automated assay on the Serono SRI™ for the measurement of cortisol in serum, heparinised plasma and urine. The assay incorporates a specific polyclonal antibody to cortisol and cortisol conjugated to alkaline phosphatase as a label. Following immunoincubation, bound and free labelled cortisol are separated by magnetic sedimentation of the antibody complex. Phenolphthalein is liberated by the enzymatic hydrolysis of the substrate (phenolphthalein monophosphate) and the absorbance generated is measured as the assay end-point. All processing steps are performed by the SRI.
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This study describes the performance of a fully auThe measurement of serum cortisol is useful in the tomated enzyme immunoassay for cortisol using the evaluation of both adrenal and pituitary function and SRI™ analyzer (Serono Diagnostics) with reference in the differentiation of the pathological conditions to its suitability for routine use in a clinical chemistry associated with dysfunction of the pituitary-adrenal laboratory, axis (1) . Urinary cortisol provides high diagnostic sensitivity for hypercorticoidism (2) . Immunoassays for the determination of urinary cortisol tend to omit Materials and Methods
Chromatographie purification Steps, SO that cortisol
Assay specific reagents were provided by Serono Diagnostics metabolites contribute to the analytical value. In view s · A ·» Coinsins, Switzerland.
of the lack of Specificity of these methods, sample Human serum was collected from donors (n = 200) at a blood pretreatment is recommended (3) . transfusion clinic. Urine samples were collected from normal, ambulatory individuals (n = 29 . This rapidly (6 minutes incubation) binds to the antibody complex and is sedimented in a magnetic field. After aspiration of the liquid and washing of the solid phase, a solution of the enzyme substrate (phenolphthalein monophosphate) is added and the mixture incubated at 37 °C for 12 minutes. At the end of this period the reaction is stopped by the addition of sodium hydroxide (final pH = 10.6) and the intensity of the colour developed is measured photometrically. The intensity of the colour developed is inversely proportional to the concentration of cortisol in the sample or standard. The concentration of cortisol is calculated from a stored standard curve. The time to first result is 46 minutes; 59 samples can be processed in 120 minutes.
Precision
Within assay precision was determined by replication (n = 20) of three levels of control sera. To assess between assay precision, three levels of control sera were assayed in duplicate on ten occasions over a period of one month using 2 lots of reagents (n = 20).
Recovery and accuracy
The recovery of the assay was determined by adding pure cortisol at different levels to 5 serum pools with low endogenous levels of cortisol. Recovery of added cortisol was calculated as recommended by the ECCLS guidelines (9).
Accuracy was determined by assaying the BCR material on 6 occasions. This material is supplied with cortisol concentrations assigned by isotope dilution-mass spectrometry (ID-MS).
Specificity
The specificity of the assay was determined by measuring Ihe apparent response to various potentially cross-reacting substances. Cross-reactivity was calculated as:
Cross-reactivity (%)
Apparent cortisol dose (nmol/1) Added dose cross-reactant (nmol/1) χ 100
Dilution Accuracy was also monitored by assaying ten patient pools diluted with human cortisol-free serum.
Expected values
Reference ranges for normal subjects were established using data from serum (n = 200) and urine (n = 29) samples collected from healthy blood donors. Matched serum samples (n = 36) were also collected at 09.00 hours and midnight from healthy volunteers. Reference ranges were calculated as 2.5 and 97.5 percentiles.
Correlation with other immunoassays
The SRI Cortisol assay was compared with the following assays: Diagnostic Products Corporation, Coat-a-Count (radioimmunoassay). Amerlite Diagnostics Limited, Amerlite (luminescence-enhanced enzyme immunoassay). Abbott Diagnostics, TDx (fluorescence polarization immunoassay). Boehringer Mannheim, Enzymun-Test (enzyme immunoassay). Regression lines were calculated using the method of Passing & Bablok (10).
Application to urine
Urine samples were collected without preservative as 24 hour collections. Urinary cortisol values were determined with and without prior sample pretreatment. Briefly, the pretreatment was performed as follows: 500 μΐ of freshly collected urine were extracted in 2.5 ml of ice-cold dichloromethane. Following removal of the solvent by evaporation, the extract was reconstituted in human cortisol-free serum and assayed as a serum sample. The precision and accuracy of the method was similar to that of the serum assay. The average recovery of this method was 96.5 ± 11.9%. This was assessed by addition of pure cortisol to urine, followed by extraction and calculation of the recovery as recommended (8) .
Results

Precision
Within and between assay precision are summarised in table 1.
Detection limit
The detection limit of the assay was defined as the concentration of cortisol equivalent to the mean absorbance of the zero standard minus two standard deviations calculated from 20 replicates of the zero analyte standard.
The detection limit of the assay determined on four occasions was typically less than 5 nmol/1 (mean = 2.7 nmol/1, range = 1.9 to 3.3 nmol/1). Table 3 (c) shows reference ranges for normal subjects using the SRI Cortisol assay. These ranges are intended only as a guide and may vary depending on the population studied. They are in good agreement with previously published reference ranges (1). Unextracted urine samples give higher cortisol concentrations than the corresponding extracted samples.
Correlation with other immunoassays Figure 1 shows comparisons of cortisol results using four different immunoassays. In general, a good correlation was obtained between SRI Cortisol and the other products. 
Conclusion
This paper describes the performance of a fully automated enzyme immunoassay for the measurement of cortisol in serum, heparinised plasma and urine. The range (5 -1656 nmol/l) and detection limit (< 5 nmol/l) of the assay make it suitable for all clinical applications of the assay. The assay has good specificity for cortisol. Only prednisolone (a therapeutic drug with marked structural similarity to cortisol) shows a significant cross-reaction. Samples from patients taking prednisolone are therefore contra-indicated. The concentrations of cortisol measured with this assay show good agreement with values measured with other immunoassays and by isotope dilutionmass spectrometry. Urine samples should be extracted prior to assay, because the method co-measures cortisol metabolites in urine.
In conclusion, the SRI Cortisol assay on the SRI analyzer fulfills all the necessary criteria for routine clinical analysis. The SRI provides walk-to, walkaway automation, random access and batch modes of operation and uses stored standard curve calibration. The time to first result for a cortisol assay is 46 minutes and thereafter two results every two minutes. 
